Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.5% of adults in Stockton have diagnosed diabetes — 1.5 points above the U.S. 12% figure. Census population 320,804. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Stockton clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Stockton storefront.
Umbilical Cord Tissue Allograft in Stockton, CA for clinics & physicians. HCT/P 361 compliant umbilical co… Compliance support & pricing — contact Hawk Medical.
Stockton is a city of 250k–500k (320,804 Census). CDC PLACES (2023, crude) estimates 13.5% of adults in Stockton have diagnosed diabetes — 1.5 points above the U.S. 12% figure. Adult arthritis here is 20.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Umbilical Cord Tissue Allograft notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Stockton we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 13.5% of adults in Stockton have diagnosed diabetes — 1.5 points above the U.S. 12% figure.
If you already buy umbilical cord tissue allograft elsewhere, use this page as a check: homologous-use language, current Noridian Healthcare Solutions article IDs, and PLACES 13.5% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.5% of adults — 1.5 points above the U.S. 12% figure. Obesity is 31.8%; arthritis is 20.4%. That is place-level BRFSS modeling, not a clinic census and not a Stockton trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JE reviewers and surveyors expect — not a brochure.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
If you operate in California and another MAC state, say it on the first call. JE will not port 1:1. We would rather split utilization than watch a sister clinic copy Stockton tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Stockton, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Stockton is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Stockton — 1.5 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Stockton. Useful for joint-program math; still needs a diagnosis and privileging.
No Stockton storefront. Joe Bradley is an active practice owner. umbilical cord tissue allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.